Drugs / 7-valent pneumococcal-CRM197 conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00378417 | Mar 1995 → Mar 1999 | otitis media, pneumococcal infection | Finnish Institute for Health and Welfare | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 7-valent pneumococcal-CRM197 conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00378417 ↗ |
| Known as | PCV7 | “Children had been vaccinated at 2, 4, 6, and 12 months of age with 7-valent pneumococcal capsular polysaccharide, CRM197 conjugate vaccine (PCV7), or a control vaccine.” PMID 23658394 ↗ May 2013 |
| Modality | Vaccine | “heptavalent pneumococcal polysaccharide-CRM197 conjugate vaccine” PMID 11172176 ↗ Feb 2001 |